Fit for repurpose
Drugs that can be used for new indications offer a potentially cheaper pathway – but only if the investors can recoup their costs
With the cost of developing a new drug from scratch topping a billion dollars, the attraction of finding a cheaper way to address unmet medical needs is obvious. How about taking an existing drug whose safety – and side-effect profile – is already established, and proving it works in another disease?